Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-741P is a processed pseudogene derived from the U6 small nuclear RNA gene, a core component of the spliceosome complex responsible for pre-mRNA splicing in eukaryotes[1][3]. As a pseudogene, RNU6-741P does not produce a functional RNA molecule or protein and is generally considered noncoding and nonfunctional. While functional U6 snRNA is essential for spliceosome activity, most U6-derived pseudogenes, including RNU6-741P, are retrotransposed genomic elements lacking regulatory or protein-coding capability[1][3]. There is no evidence or clinical indication that RNU6-741P is involved in human disease as a molecular target, biomarker, or therapeutic agent[2][3]. Pseudogenes like RNU6-741P can sometimes exert regulatory functions at the RNA level, but no evidence for such a role exists for this specific pseudogene[2]. U6 snRNA, the parent molecule, is well-studied and plays an essential role in splicing; pseudogenes derived from U6 snRNA (including RNU6-741P) typically do not retain this function[1][3]. Pseudogenes broadly may influence disease by regulating parental gene expression (e.g., through antisense interference or acting as “decoys” for microRNAs), but this has not been specifically described for RNU6-741P[2]. In summary, RNU6-741P is not a drug target or functional receptor/enzyme/transporter, but a genomic pseudogene with no direct therapeutic or biological relevance[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 741, pseudogene (RNU6-741P).